Health and Fitness Health and Fitness
Thu, September 16, 2010
[ Thu, Sep 16th 2010 ] - Market Wire
GTx Announces Corporate Presentation at the UBS Global Life Sciences Conference
[ Thu, Sep 16th 2010 ] - Market Wire
Alkermes Stock Trading Halted Today
[ Thu, Sep 16th 2010 ] - Market Wire
BioCryst Reports Positive Results From A Phase 2 .. 8 Combined with Allopurinol in Patients with Gout
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ] - Market Wire
Gileads HIV-Einzeltablette, das aQuada-Prparat, z .. 8-wchiger Phase-II-Studie hohe virale Suppression
[ Wed, Sep 15th 2010 ] - Market Wire
LifePoint Hospitals Announces $150 Million Stock Repurchase Program
[ Wed, Sep 15th 2010 ] - Market Wire
Illumina and Wellcome Trust Sanger Institute Anno .. e Completed Genome for Endangered Tasmanian Devil
[ Wed, Sep 15th 2010 ] - Market Wire
LecTec Corporation Announces Director Plans to Retire
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien maakt hoogtepunten beleggersvergadering bekend
[ Wed, Sep 15th 2010 ] - Market Wire
PPD Named to InformationWeek 500 List of Top Technology Innovators
[ Wed, Sep 15th 2010 ] - Market Wire
Phase I/II Data Published in New England Journal .. Incyte JAK Inhibitor, INCB18424, Provides Marked
[ Wed, Sep 15th 2010 ] - Market Wire
Qtrax Beta Available in India
[ Wed, Sep 15th 2010 ] - Market Wire
Baxter International Third Quarter 2010 Financial Results Conference Call
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien gibt Hhepunkte seiner Investorenversammlung bekannt
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien comunica i punti salienti emersi nel corso dell'assemblea degli investitori
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien anuncia los temas ms importantes tratados en la reunin de inversores
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien Anuncia Destaques da Assembl©ia de Investidores
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien annonce les points forts de sa r©union avec les investisseurs
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien Announces Highlights from Investor Meeting
[ Wed, Sep 15th 2010 ] - Market Wire
Forest Laboratories, Inc. Finalizes Previously Di .. vernment Investigations and Related Civil Qui Tam
[ Wed, Sep 15th 2010 ] - Market Wire
Healthways Ranks #8 on 2010 InformationWeek 500
[ Wed, Sep 15th 2010 ] - Market Wire
Crozer-Keystone Health System Joins Aetna Better Health Network
[ Wed, Sep 15th 2010 ] - Market Wire
Impax Laboratories to Present at the UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
Bond Labs Expands Resurrection(TM) into the Atlanta and Savannah Markets
[ Wed, Sep 15th 2010 ] - Market Wire
BioCryst to Present Peramivir Data at the 50th Annual ICAAC Meeting
[ Wed, Sep 15th 2010 ] - Market Wire
Micromet to Present at the 2010 UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
Medical Action Industries to Present in the 2010 UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
Celgene Corporation to Present at the UBS 2010 Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
ArthroCare to Present at UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
BioCryst Reports Results from Two Forodesine Oncology Studies
[ Wed, Sep 15th 2010 ] - Market Wire
SuperGen to Present at UBS Global Life Sciences Conference on September 22nd

SuperGen to Present at UBS Global Life Sciences Conference on September 22nd


Published on 2010-09-15 03:40:34 - Market Wire
  Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that Mohammad Azab, M.D., Chief Medical Officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 22nd in New York.

SuperGen's presentation will begin at 10:00 a.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. The webcast will be archived for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].

Contributing Sources